secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspira Women's Health Inc. (AWHL)
CIK:        0000926617
Form:       8-K
Filed at:   2025-11-14T23:59:59+00:00
Accession:  0000926617-25-000004
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aspira Women's Health Q3 revenue flat at $2.3M; gross margin expands to 64.1%
-----------------------------------------------------------------------------

- Nine-month gross profit $4.5M (+12.2% YoY); margin 64.1% vs 58.4%.
- Operating expenses down 34% to $11.1M; cash burn reduced 54.5% to $5.0M.
- Average unit price per test +7% YoY; sales per FTE up 167% in Q3.
- Shift to profitable revenue; OvaSuite adopted by large IDN for O-RADS 4 patients.
- Progress on ENDOinform endometriosis diagnostic; milestones toward commercial readiness.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/926617/000092661725000004/0000926617-25-000004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/926617/000092661725000004/awhl-20251114x8k.htm
  HTML page:      https://secwatch.observer/filing/0000926617-25-000004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer